Cargando…
Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors
Malignant peripheral nerve sheath tumor (MPNST) is a type of soft-tissue sarcoma strongly associated with dysfunction in neurofibromin; an inhibitor of the RAS pathway. We performed high-throughput screening of an array of FDA approved and promising agents in clinical development both alone and in c...
Autores principales: | Kahen, Elliot John, Brohl, Andrew, Yu, Diana, Welch, Darcy, Cubitt, Christopher L., Lee, Jae K., Chen, Yunyun, Yoder, Sean J., Teer, Jamie K., Zhang, Yonghong O., Wallace, Margaret R., Reed, Damon R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978249/ https://www.ncbi.nlm.nih.gov/pubmed/29854299 http://dx.doi.org/10.18632/oncotarget.25181 |
Ejemplares similares
-
The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation
por: Brohl, Andrew S., et al.
Publicado: (2017) -
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines
por: Welch, Darcy, et al.
Publicado: (2019) -
TRIM28 congenital predisposition to Wilms’ tumor: novel mutations and presentation in a sibling pair
por: Moore, Colin, et al.
Publicado: (2020) -
Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma
por: Kahen, Elliot, et al.
Publicado: (2016) -
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy
por: Welch, Darcy L., et al.
Publicado: (2023)